EVALUATION OF NEW CHEMOTHERAPEUTIC AGENTS IN THE TREATMENT OF MULTIPLE MYELOMA .4. L-PHENYLALANINE MUSTARD (NSC-8806)
- 1 January 1962
- journal article
- research article
- Vol. 21 (21), 87-99
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- CLINICAL EXPERIENCE WITH THE USE OF R48 (NN-DI-2′-CHLOROETHYL-2′-NAPHTHYLAMINE)Annals of the New York Academy of Sciences, 1958
- INITIAL CLINICAL TRIAL OF THE NITROGEN MUSTARD ANALOGUES OF CHLOROQUINE AND QUINACRINE: A PRELIMINARY REPORTAnnals of the New York Academy of Sciences, 1958
- TREATMENT OF MULTIPLE MYELOMA WITH URETHANJAMA, 1951
- MULTIPLE MYELOMA. III. EFFECT OF URETHANE THERAPY ON PLASMA CELL GROWTH, ABNORMAL SERUM PROTEIN COMPONENTS AND BENCE JONES PROTEINURIA 1JCI Insight, 1950